PD-1 (Programmed Cell Death Protein 1) is an inhibitory receptor expressed on the surface of T cells and other immune cells, while PD-L1 (Programmed Cell Death Ligand 1) is predominantly expressed on tumor cells and certain immune cells. This evidence concerns the gene CD274 and neoplasm.